🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Holly Yu

Pfizer (United States)

ORCID: 0000-0001-8625-4201

Also affiliated with Health Economics and Outcomes Research (United Kingdom)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities”.

Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities

Vaccine(2020)10.1016/j.vaccine.2020.06.081

N/A

0DataRank · unranked

14 citations

Lindsay T. Keegan, Matthew H. Samore, Karim Khader, Justin J. O’Hagan, Holly Yu +3 more

Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset

Clinical Infectious Diseases(2022)10.1093/cid/ciac841

N/A

0DataRank · unranked

15 citations

Margaret A. Olsen, Dustin Stwalley, Holly Yu, Erik R. Dubberke, John M. Sahrmann

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad343

N/A

0DataRank · unranked

5 citations

Margaret A. Olsen, Matthew Keller, Holly Yu, Erik R. Dubberke, John M. Sahrmann